GxPinnacle Logo
Skip to content

What Do Inspectors Check for Retraining, Competency and Continuous Improvement in Pharmacovigilance?

Pharmacovigilance systems must ensure ongoing competence through retraining and continuous improvement. Regulators expect training updates after SOP changes, audit findings, and regulatory updates, supported by evidence of maintained competency.

For: Founders, CEOs & MDs·PV Leads·QA/Compliance·Scientists tasked with documentation

Alignment: Global pharmacovigilance principles (ICH-aligned) and inspection practices

Most useful when: Preparing for inspection, setting up a process, or closing a documentation gap

Key points

  • Pharmacovigilance systems must ensure personnel remain competent through retraining and continuous learning.
  • Retraining must be triggered by SOP changes, regulatory updates, audit findings, and performance issues.
  • Competency must be demonstrated through training completion, assessment, and performance outcomes.
  • Training programmes must evolve based on findings, metrics, and regulatory expectations.
  • Retraining activities must be documented and tracked.
  • Inspection-ready evidence must demonstrate that training is updated, effective, and supports ongoing competence.

What inspectors expect

Each point below should be supported by controlled documents and traceable records.

  • Personnel must remain competent over time.
  • Retraining must occur following significant changes.
  • Training effectiveness must be assessed.
  • Training programmes must be updated based on findings.
  • Training must support continuous improvement of the PV system.

Summary

Inspectors assess whether pharmacovigilance systems ensure ongoing competence through retraining and continuous improvement. They review retraining triggers, competency evidence, training updates, and whether training programmes evolve based on audits, metrics, and regulatory changes.

Common questions

These are the questions this page is designed to answer directly.

  • When is retraining required in pharmacovigilance?
  • What do inspectors check for PV retraining?
  • How is competency assessed in pharmacovigilance?
  • What triggers retraining in PV systems?
  • How do you ensure staff remain competent in pharmacovigilance?
  • What is continuous improvement in PV training?
  • How do regulators assess training effectiveness?
  • How do you manage retraining after SOP updates?
  • What evidence is required for competency in PV?
  • How do you improve training programmes over time?

Evidence objects inspectors expect

Retraining Records

  • Training completion following SOP updates
  • Retraining after audit findings or CAPA
  • Evidence of retraining following regulatory changes
  • Documentation of retraining completion timelines

Competency Assessment Evidence

  • Knowledge checks or quiz results
  • Assessment scores or certification outcomes
  • Manager verification of competence
  • Evidence of correct task performance post-training

Training Update and Improvement Records

  • Updates to training materials following process changes
  • Revision of training content based on audit findings
  • Continuous improvement actions linked to training gaps
  • Evidence of training programme evolution

CAPA and Training Linkage

  • Training updates triggered by CAPA
  • Corrective actions requiring retraining
  • Documentation linking findings to training improvements
  • Verification that training changes address root causes

Training Effectiveness Monitoring

  • Review of training outcomes and performance metrics
  • Reduction in errors or deviations following retraining
  • Trend analysis of training effectiveness
  • Feedback from trainees or managers

Regulatory Basis (Primary Sources)

  • GVP Module I – requirement for competent personnel and continuous oversight of competence
  • GVP Module II – requirement for maintaining effective PV system documentation and processes
  • ICH E2D – requirement for trained and competent staff managing safety data
  • MHRA GPvP guidance – expectations for training updates and competence
  • FDA pharmacovigilance guidance – requirement for maintaining effective training and competence

Typical Inspection Questions (What Inspectors Ask)

  • What triggers retraining in your organisation?
  • How do you ensure staff remain competent?
  • Show me retraining following this SOP update.
  • How do you assess training effectiveness?
  • How do you improve your training programme over time?

Failure patterns

SOP changes occur without retraining affected personnel.

Training is completed but competency is not assessed.

Audit findings do not trigger training updates.

Training programme does not evolve over time.

Staff continue performing tasks without updated knowledge.

What good looks like

  • Clear retraining triggers linked to SOP, regulatory, and audit changes.
  • Documented retraining with evidence of completion.
  • Assessment of competency following training.
  • Training updates aligned with system improvements.
  • Continuous improvement of the training programme.

Operationalisation

  • Define retraining triggers within the training SOP.
  • Schedule retraining following SOP updates or audit findings.
  • Assess competency using quizzes, checks, or manager verification.
  • Update training materials based on regulatory or operational changes.
  • Monitor training effectiveness through performance metrics.
  • Ensure continuous improvement of training processes.

Need regulatory documentation today?

Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.

Related pre-built documentation inside the app

Get AccessLog In

FAQ

When is retraining required in pharmacovigilance?

Retraining is required following SOP updates, regulatory changes, audit findings, CAPA, or when performance issues indicate a need for additional training.

How is competency assessed in pharmacovigilance?

Competency is assessed through training completion records, knowledge checks, assessments, and verification that individuals can perform their tasks correctly.

Do inspectors review retraining in pharmacovigilance?

Yes. Inspectors review whether retraining occurs after changes and whether staff remain competent to perform PV activities.

What is continuous improvement in PV training?

Continuous improvement involves updating training programmes based on audit findings, regulatory changes, and performance data to ensure ongoing competence.

How do you ensure staff remain competent over time?

By combining initial training, periodic refresher training, retraining after changes, and ongoing assessment of performance and knowledge.

What happens if retraining is not performed?

Failure to retrain staff can result in inspection findings due to lack of competence and increased compliance risk.

Sources

Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.

European Medicines Agency (EMA)

  • Guideline on good pharmacovigilance practices (GVP) – Module I
    View source
  • Guideline on good pharmacovigilance practices (GVP) – Module II
    View source

FDA

ICH

MHRA